Energenesis Biomedical CO.,LTD. (6657.TW)

TWD 61.9

(6.17%)

EBITDA Summary of Energenesis Biomedical CO.,LTD.

  • Energenesis Biomedical CO.,LTD.'s latest annual EBITDA in 2023 was -244.57 Million TWD , down -1.47% from previous year.
  • Energenesis Biomedical CO.,LTD.'s latest quarterly EBITDA in 2024 Q2 was -42.96 Million TWD , down -16.17% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported an annual EBITDA of -241.04 Million TWD in 2022, down -148.37% from previous year.
  • Energenesis Biomedical CO.,LTD. reported an annual EBITDA of -97.05 Million TWD in 2021, up 11.09% from previous year.
  • Energenesis Biomedical CO.,LTD. reported a quarterly EBITDA of -36.98 Million TWD for 2024 Q1, up 29.55% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported a quarterly EBITDA of -50.25 Million TWD for 2023 Q1, down -26.92% from previous quarter.

Annual EBITDA Chart of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Created with Highcharts 11.1.0YearsEBITDA20192019.520202020.520212021.520222022.52023-300000000 TWD-250000000 TWD-200000000 TWD-150000000 TWD-100000000 TWD-50000000 TWD

Historical Annual EBITDA of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -244.57 Million TWD -1.47%
2022 -241.04 Million TWD -148.37%
2021 -97.05 Million TWD 11.09%
2020 -109.15 Million TWD 16.89%
2019 -131.33 Million TWD 0.0%

Peer EBITDA Comparison of Energenesis Biomedical CO.,LTD.

Name EBITDA EBITDA Difference
Apex Biotechnology Corp. 221.06 Million TWD 210.638%
Sinphar Pharmaceutical Co.,Ltd. 582.94 Million TWD 141.956%
Panion & Bf Biotech Inc. 327.21 Million TWD 174.744%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 473.81 Million TWD 151.619%
GenMont Biotech Incorporation 71.76 Million TWD 440.788%
Abnova (Taiwan) Corporation 81.2 Million TWD 401.17%
Adimmune Corporation -512.42 Million TWD 52.271%
Tanvex BioPharma, Inc. -1.75 Billion TWD 86.06%
Polaris Group -1.38 Billion TWD 82.398%
UnicoCell Biomed Co., Ltd. -56.27 Million TWD -334.603%
PELL Bio-Med Technology Co. Ltd. -353.17 Million TWD 30.75%